Cost-Effectiveness of Sacubitril/Valsartan Compared with Enalapril in Patients with Heart Failure with Reduced Ejection Fraction: A Systematic Review

Background: To assess the cost-effectiveness of sacubitril/valsartan compared with enalapril in patients with heart failure with reduced ejection (HFrEF). Methods: A systematic literature search was conducted searching in major electronic databases from inception to January 1, 2021. All relevant...

Descripció completa

Dades bibliogràfiques

Autors principals:	Aziz Rezapour, Samad Azari, Jalal Arabloo, Pirhossein Kolivand, Masoud Behzadifar, Negar Omidi, Ali Sarabi Asiabar, Peyman Saberian, Hamid Pourasghari, Nicola luigi Bragazzi, Mehdi Mehrani, Shayan Shahi, Masih Tajdini
Format:	Artigo
Idioma:	Inglês
Publicat:	Tehran University of Medical Sciences 2022-10-01
Col·lecció:	Journal of Tehran University Heart Center
Matèries:	Cost-effectiveness analysis Sacubitril-valsartan Heart Failure; epidemiology Heart Failure; therapy Systematic review
Accés en línia:	https://jthc.tums.ac.ir/index.php/jthc/article/view/1752
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!